By Professor David Goldstein

Conference Abstracts

Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Vol. 13, pp. 66 - 66, presented at COSA's 44th Annual Scientific Meeting, 13 November 2017 - 15 November 2017, http://dx.doi.org/10.1111/ajco.12798

Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in Immunotherapy: Molecules and Mountains, Sydney, presented at COSA's 44th Annual Scientif Meeting, Sydney, http://dx.doi.org/10.1111/ajco.12798

Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wang X; Yeo R; Crowe P; Goldstein D; Hogg R; Dilda P; Yang JL, 2016, 'Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, GERMANY, Munich, Vol. 69, pp. S37 - S38, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, GERMANY, Munich, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32693-4

McCrary JM; Park S; Goldstein D, 2016, 'A SYSTEMATIC REVIEW AND DELPHI SURVEY OF ASSESSMENT STRATEGIES FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 128 - 128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Battaglini E; Goldstein D; Park SB, 2016, 'ASSESSING THE IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN AUSTRALIA VIA A PATIENT SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McCrary JM; Park S; Goldstein D, 2016, 'CLINICIAN AND NURSE REPORTING HABITS FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 129 - 129, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips P; Sharbeen G; Youkhana J; Mawson A; McCarroll J; Akerman A; Goldstein D, 2016, 'MutY-Homolog Modulates Pancreatic Cancer Cell Survival and Chemoresistance', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 45, pp. 1534 - 1534, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386978400183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Youkhana J; Mawson A; Mccarroll J; Goldstein D; Phillips P, 2016, 'MutY-homolog modulates pancreatic cancer cell survival and chemoresistance', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tempero MA; Cardin DB; Goldstein D; O'Reilly EM; Philip AP; Riess H; Macarulla T; Yung L; Li M; Lu BD; Biankin A, 2016, 'APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.tps473

Yip S; Harvie R; Martin AJ; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Strickland A; Zalcberg JR; Simes J; Goldstein D; Pavlakis N, 2016, 'Evaluation of circulating VEGF based biomarkers in INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.64

McNamara MG; Bridgewater JA; Lopes A; Wasan H; Malka D; Jensen HR; Okusaka T; Knox JJ; Wagner AD; Cunningham D; Shannon J; Goldstein D; Moehler MH; Bekaii-Saab TS; Valle JW, 2016, 'Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.382

Farrar MA; KAndula T; Murray J; Goldstein D; Krishnan A; PArk S, 2016, 'Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?', in Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?, Elsevier, Vol. 127, pp. e13, presented at ANZAN Biennial Clinical Neurophysiology Workshop, http://dx.doi.org/10.1016/j.clinph.2015.11.029

Sharbeen G; McCarroll J; Liu J; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharbeen G; Liu J; McCarroll J; Limbri L; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritchie GE; Fernando M; Goldstein D, 2015, 'RITUXIMAB TO TREAT GEMCITABINE INDUCED HEMOLYTIC URAEMIC SYNDROME IN THREE PATIENTS WITH PANCREATIC ADNENOCARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 11, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J; Donoghoe M; Walker K; Burge ME; Gananadha S; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115

Stein A; Arnold D; Bechstein WO; Bridgewater JA; Goldstein D; Jensen LH; Kasper S; Kluempen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose JN; Markus R; Shannon JA; Sinn M; Karl-Heinz W; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1): A randomized, multidisciplinary, multinational phase III trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4140

Chan D; Goldstein D; Sjoquist KM; Pavlakis N, 2015, 'Antiangiogenic agents (AAs) in metastatic oesophago-gastric cancer (mOGC): A systematic review and meta-analysis', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15111

Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Kim JW; Yip S; Simes J; Zalcberg JR; Goldstein D, 2015, 'INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastrointestinal Trials Group (AGITG)-Final overall and subgroup results', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4003

Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4153

Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu BD; Von Hoff DD, 2015, 'Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15299

Wege H; Arnold D; Bechstein WO; Bridgewater J; Goldstein D; Jensen LH; Kasper S; Klumpen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose J; Rentsch M; Shannon J; Sinn M; Weiss KH; Stein A, 2015, 'ADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN COMPARED TO OBSERVATION AFTER CURATIVE INTENT RESECTION OF CHOLANGIOCARCINOMA AND MUSCLE INVASIVE GALLBLADDER CARCINOMA (ACTICCA-1) - A RANDOMIZED, MULTIDISCIPLINARY, MULTINATIONAL PHASE III TRIAL', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, Vol. 62, pp. S845 - S846, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)31489-6

Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP; Kavallaris M; Mccarroll J, 2015, 'Erratum: Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers (Molecular Pharmaceutics (2013) 10: 6 (2435−2444) DOI: 10.1021/mp400049e)', in Molecular Pharmaceutics, Vol. 12, pp. 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00092

Barbour A; O'Rourke N; Samra JS; Haghighi KS; Kench J; Mitchell J; Pavlakis N; Burge ME; Fawcett J; Gananadha S; Harris M; Aghmesheh M; Chua YJ; Joubert WL; Chan MMK; Chandrasegaram MD; Yip S; Simes J; Gebski V; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 33, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 15 January 2015 - 17 January 2015, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.387

Wang X; Goldstein D; Crowe P; Yang JL, 2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)31921-9

Tempero MA; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip P; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: a Phase III Trial of nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) vs Gem Alone as Adjuvant Therapy for Patients (pts) with Resected Pancreatic Cancer (PC)', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 43, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zilliacus E; Meiser B; Taouk M; Watts K; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Goldstein D, 2013, 'WORKING WITH PATIENTS FROM CULTURALLY AND LINGUISTICALLY DIVERSE BACKGROUNDS: PERSPECTIVES OF ONCOLOGY HEALTH PROFESSIONALS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 9, pp. 130 - 130, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Girgis A; Kaye B; Bonaventura BA; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, Vol. 31, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Girgis A; Bennett BK; Bonaventura T; Boyle F; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2012, 'CURRENT CARE AND NEEDS OF ADULT CANCER SURVIVORS - A CROSS-SECTIONAL SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 356 - 357, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802650&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sze M; Butow PN; King M; Goldstein D; Jefford M; Girgis A; Eisenbruch M; Bell M; Vaccaro L; Dong R; Asghari M; Tattersall MH; Hui R, 2011, 'Cancer in a country not your own: Illness perceptions and distress in immigrant versus native-born cancer patients', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 81 - 81

Butow PN; Lobb EA; Schofield PR; Goldstein D; Eisenbruch M; Girgis A; Jefford M; King M; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse (CALD) backgrounds: the interpreter perspective', in Psycho-oncology, John Wiley & Sons, New York, pp. 46 - 46

Butow PN; Lobb E; Schofield PR; Jefford M; Goldstein D; King M; Eisenbruch M; Girgis A; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse backgrounds – the interpreters’ perceptions of roles, challenges, and support needs', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 207 - 207

Aldridge L; McGrane J; Butow PN; Goldstein D; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, and Arabic-speaking cancer patients in New South Wales', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 221 - 221

Aldridge L; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, Arabic, and English-speaking cancer patients in New South Wales', in Psycho-oncology, John Wiley & Sons, New York, pp. 117 - 117

Butow PN; Girgis A; Goldstein D; Eisenbruch M; Schofield PR; Jefford M; King M; Duggal-beri P; Sze M; Mikhail M; Lobb E, 2008, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in Psycho-oncology, John Wiley & Sons, New York, Vol. 17, pp. S280 - S280, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200539&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E; Aldridge L; Grayson NM; Faraji S; Threlfall T, 2008, 'Conducting research with culturally and linguistically diversre cancer patients: methodological issues', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 40 - 40

Butow PN; Girgis A; Goldstein D; Eisenbruch M; Schofield PR; Jefford M; King M; Duggal-beri P; Mikhail M; Sze M; Lobb E, 2008, 'Unmet needs in Chinese, Greek and Arabic speaking cancer patients in Australia', in Psycho-oncology, John Wiley & Sons, New York, Vol. 17, pp. S7 - S7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A95 - A96

Sze M; Duggal-beri P; Butow PN; Mikhail M; Eisenbruch M; Goldstein D; Schofield PR; Jefford M; King M; Girgis A, 2007, 'Low psychological service utilisation in cancer – does it mean CALD patients cope better', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A96 - A96

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Psychological morbidity or unmet needs of cancer patients from culturally and linguistically diverse (CALD) backgrounds', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A67 - A67

Preprints

Best M; Bartley N; Napier C; Fisher A; Ballinger M; Thomas D; Goldstein D; Tucker K; Biesecker B; Butow P, 2022, Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study, , http://dx.doi.org/10.21203/rs.3.rs-1190781/v1

Kokkinos J; Sharbeen G; Ignacio RM; Pandzic E; Youkhana J; Boyer C; Haghighi K; Gunawarman M; Goldstein D; Gebski V; Pajic M; Pitiyarachchi O; Davis M; Schulstad G; Arkell OSM; Kopecky C; Gonzales-Aloy E; Erkan M; Morton J; Kavallaris M; Gunning P; Hardeman E; Johns A; Gill A; Whan R; Mawson A; McCarroll J; Phillips P; Australian Pancreatic Cancer Genome Initiative , 2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, , http://dx.doi.org/10.1101/2022.09.29.510034

Habibalahi A; Moses D; Campbell J; Mahbub S; Barbour AP; Samra JS; Haghighi KS; Gebski VJ; Goldstein D; Goldys E, 2021, Computed Tomography Radiomics Signatures: Sensitive biomarkers for clinical decision support in pancreatic cancer- a pilot study, , http://dx.doi.org/10.1101/2021.12.03.21267217

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey S; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill A; Gonzales-Aloy E; Kokkinos J; Gebski V; Turner N; Apte M; Davis TP; Morton JP; Haghighi K; Phillips PA, 2020, Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition, , http://dx.doi.org/10.1101/2020.07.12.199638

Other

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.c.6512931.v1

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.c.6512931

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428180.v1

Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428180

Back to profile page